<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="191261">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00602953</url>
  </required_header>
  <id_info>
    <org_study_id>042007-021</org_study_id>
    <secondary_id>1K23RR02447001</secondary_id>
    <nct_id>NCT00602953</nct_id>
  </id_info>
  <brief_title>Role of Pancreatic Triglyceride Content in Beta-cell Function</brief_title>
  <official_title>Role of Pancreatic Triglyceride Content in Beta-cell Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates if fat accumulates in the pancreas in individuals at risk of developing
      obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict
      the residual functional capacity of the pancreas (insulin secretion).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between panctreatic triglyceride and beta-cell function</measure>
    <time_frame>August/2012</time_frame>
    <description>To evaluate the association between pancreatic triglyceride (TG) content measured by the magnetic resonance spectroscopy (MRS) technique and beta-cell function as measured by frequently sampled intravenous glucose tolerance test (FSIVGTT) in volunteers with a wide range of body mass index (BMI).</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">101</enrollment>
  <condition>Obesity</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <description>Normal weight and normal glucose tolerance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-diabetes</arm_group_label>
    <description>Impaired fasting glucose of impaired glucose tolerance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight</arm_group_label>
    <description>Overweight or obese volunteers, but with normal fasting and postprandial glucose levels.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 diabetes</arm_group_label>
    <description>Patients with type 2 diabetes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 1 diabetes</arm_group_label>
    <description>Patients with type 1 diabetes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention planned.</intervention_name>
    <description>This is a cross-sectional observational study, no intervention is planned.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Pre-diabetes</arm_group_label>
    <arm_group_label>Overweight</arm_group_label>
    <arm_group_label>Type 2 diabetes</arm_group_label>
    <arm_group_label>Type 1 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We enroll adult volunteers of all ethnicities who have no contraindications to the study
        procedures or use medications that interfere with our measurements.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults without prior history of pancreatic disease (other than diabetes)

        Exclusion Criteria:

          -  use of unapproved medications

          -  contraindications to the MRI procedure

          -  contraindications to frequent blood draws

          -  pregnancy

          -  use of more than 2 alcoholic drinks/day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ildiko Lingvay, MD, MPH, MSCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 22, 2013</lastchanged_date>
  <firstreceived_date>October 25, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Ildiko Lingvay</investigator_full_name>
    <investigator_title>MD, MPH, MSCS</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
